Biocon Biologics has accomplished a major breakthrough in the U.S. with wide-ranging market access for Yesintek (ustekinumab-kfce), its biosimilar to Stelara, marking its first commercial launch in the country as a fully combined biosimilar company.
A leading contract research and manufacturing organization, Akums Drugs & Pharmaceuticals, has established a patent for its novel extended-release invention of doxylamine and pyridoxine.
An innovation in Space Medicine has been made through the partnership of the Indian Space Research Organisation (ISRO), Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST),and the Department of S...
Eli Lilly’s experimental weight-loss pill, orforglipron, achieved nearly 8% weight loss and notable blood sugar reduction in a late-stage trial for patients with type 2 diabetes. The once-daily oral drug exceeded Wall Street expectations, triggering
In an exclusive interaction with India Pharma Outlook, Chandra Ganjoo, Group CEO of Trivitron Healthcare, discusses how MedTech in India is advancing healthcare through AI-driven diagnostics, local manufacturing, and policy support...
The Authentication Solution Providers’ Association (ASPA) will organize an Open House event on April 24, 2025, at Anantara Downtown Dubai, starting 5:00 PM onwards aimed at protecting consumers, businesses, and economies from the growing threat of
With the increasing scrutiny on drug safety and efficacy, understanding impurities is more important than ever and ever evolving guidelines are not aiding the efforts. To address those lacunas, Eminence has come up with 3rd Annual Pharma Impurity Con
A promising therapeutic option has been proposed at the Jawaharlal Nehru Centre for Advanced Scientific Research for treating...
Researchers believe that they have unearthed a fresh genetic cause of neurodevelopmental disorders that have never before...
Novartis is launching its latest investment initiative shortly after President Donald Trump introduced sweeping new tariffs on...